About Nuwellis Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.nuwellis.com/
Frequently Asked Questions
What is the 52-week range for NUWE?
The 52-week high is $172.9 and the 52-week low is $0.7112.
What is the P/E ratio for NUWE?
The P/E ratio data is currently unavailable.
What is the dividend yield for NUWE?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -211.49%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -125.63%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.10.
Analyst Recommendation Trends
Wall Street analyst consensus for NUWE over the last few months:
Latest NUWE News
Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical Conferences
Company to engage clinicians across three key growth markets and highlight the Aquadex SmartFlow® system for precise fluid managementMINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced its participation in four leading medical conferences in October spanning pediatrics, critical care, and heart failure. Across the events, Nuwellis will engage directly
Nuwellis To Participate In Four Medical Conference This Month To Present Data, Discuss Role Of Its Aquadex SmartFlow System
Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced its participation in four leading medical conferences in October
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers IM Cannabis (NASDAQ:IMCC) stock increased by 246.0% to $6.02 during Friday's regular session. The market value of their outstanding shares is at $1.0 million. SkyAI (NASDAQ:SKYA) stock rose 20.43% to
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers IM Cannabis (NASDAQ:IMCC) stock rose 108.5% to $3.63 during Friday's pre-market session. The market value of their outstanding shares is at $1.0 million. Alaunos Therapeutics (NASDAQ:TCRT) shares increased
Nuwellis Reports 31 Aquadex Console Sales in 2026, Expanding Recurring Revenue Opportunity
The medical technology company’s growing installed base follows 26% U. S.
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Aethlon Medical (NASDAQ:AEMD) shares rose 330.8% to $6.16 during Thursday's regular session. The market value of their outstanding shares is at $1.0 million. bioAffinity Technologies (NASDAQ:BIAF) shares
Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue Opportunity
Year-to-date console sales exceed full-year console sales in seven of the past 10 years, putting Nuwellis on pace for one of its strongest years in console placementsMINNEAPOLIS, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced continued commercial momentum for its Aquadex SmartFlow® system, with 31 consoles sold year-to-date in 2026. The Company's year-to-dat
Nuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory Affairs
Experienced medical device quality and regulatory leader brings 13 years of experience supporting quality systems, regulatory compliance, audits and product developmentMINNEAPOLIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of Brian Johnson as Director of Quality and Regulatory Affairs. Johnson brings 13 years of medical device quality an
Nuwellis Advances Financial Efficiency Strategy with Improved Gross Margins
One-year anniversary of transition to contract manufacturing highlights gains in margin, quality, supply performance, and cost structure supported by strengthened balance sheet with $8.8 million in cash facilitates disciplined investment in key growth initiativesMINNEAPOLIS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, highlights continued progress under its financial eff
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-04-28 | Feldshon Archelle Georgiou | +6,744 | - | - |
| 2026-04-28 | McDonald David | +6,744 | - | - |
| 2026-04-28 | Emerson Martin J | +6,744 | - | - |
| 2026-04-28 | WALLER GREGORY D | +6,744 | - | - |